Literature DB >> 29218124

Expression of Toll-like Receptor 2 and 4 in Peripheral Blood Neutrophil Cells from Patients with Chronic Obstructive Pulmonary Disease.

Prashant Mani Tripathi1, Surya Kant1, Ravi Shanker Yadav1, Ram Awadh Singh Kushwaha1, Ved Prakash1, Sayed Husian Mustafa Rizvi2, Arshiya Parveen2, Abbas Ali Mahdi2, Iqbal Ahmad3.   

Abstract

OBJECTIVES: Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality around the world. Preliminary studies have evaluated the association between innate immunity including Toll-like receptors (TLRs) and airway samples of patients with COPD. The role of TLRs in peripheral blood neutrophils is poorly understood. Hence, this study aimed to investigate the role of TLR2 and TLR4 in peripheral blood neutrophils of COPD patients.
METHODS: A total of 101 COPD cases and an equal number of healthy controls participated in this case-control study. Peripheral blood neutrophils were isolated from all participants and cultured for 24 hours through lipopolysaccharide (LPS) stimulation. The gene expressions of TLR2 and TLR4 were assessed by real-time polymerase chain reaction. The protein levels of interleukin (IL)-8 and matrix metalloproteinase (MMP)-9 were measured in neutrophils cell culture supernatants using enzyme-linked immunosorbent assay (ELISA).
RESULTS: The levels of IL-8 and MMP-9 were significantly higher in patients with COPD compared to healthy controls. Similarly, the gene expression of TLR2 and TLR4 were increased in LPS stimulated peripheral blood neutrophils of patients with COPD. Smoke pack years was positively correlated with IL-8 levels and negatively correlated with forced expiratory volume in the first second % (r = -0.33; p = 0.023) and FEV1/forced vital capacity (FVC) (r = -0.27; p = 0.011).
CONCLUSIONS: The increased expression of TLR2 and TLR4 suggests its role in disease pathogenesis of COPD. Smoke pack years was negatively associated with spirometric parameters in COPD patients. This may help to predict the smokers without COPD who risk developing the condition in the future.

Entities:  

Keywords:  COPD; Inflammation; Innate Immunity; Neutrophils; Toll-like Receptors

Year:  2017        PMID: 29218124      PMCID: PMC5702997          DOI: 10.5001/omj.2017.92

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  36 in total

1.  The danger model: a renewed sense of self.

Authors:  Polly Matzinger
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

Review 2.  Endotoxin-stimulated innate immunity: A contributing factor for asthma.

Authors:  C E Reed; D K Milton
Journal:  J Allergy Clin Immunol       Date:  2001-08       Impact factor: 10.793

Review 3.  New molecular targets for the treatment of neutrophilic diseases.

Authors:  Peter J Barnes
Journal:  J Allergy Clin Immunol       Date:  2007-03-13       Impact factor: 10.793

Review 4.  The importance of Toll-like receptor 2 polymorphisms in severe infections.

Authors:  Joelle Texereau; Jean-Daniel Chiche; William Taylor; Gerald Choukroun; Beatrice Comba; Jean-Paul Mira
Journal:  Clin Infect Dis       Date:  2005-11-15       Impact factor: 9.079

Review 5.  COPD as a systemic disease.

Authors:  Alvar Agusti; Joan B Soriano
Journal:  COPD       Date:  2008-04       Impact factor: 2.409

6.  Isolation and functional analysis of neutrophils.

Authors:  R A Clark; W M Nauseef
Journal:  Curr Protoc Immunol       Date:  2001-05

7.  Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease.

Authors:  A Noguera; X Busquets; J Sauleda; J M Villaverde; W MacNee; A G Agustí
Journal:  Am J Respir Crit Care Med       Date:  1998-11       Impact factor: 21.405

Review 8.  Chemokines, innate and adaptive immunity, and respiratory disease.

Authors:  I Sabroe; C M Lloyd; M K B Whyte; S K Dower; T J Williams; J E Pease
Journal:  Eur Respir J       Date:  2002-02       Impact factor: 16.671

9.  Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease.

Authors:  Jaume Pons; Jaume Sauleda; Verónica Regueiro; Carmen Santos; Meritxell López; Joana Ferrer; Alvar G N Agustí; José A Bengoechea
Journal:  Respir Res       Date:  2006-04-10

10.  Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages.

Authors:  Khalil Karimi; Hadi Sarir; Esmaeil Mortaz; Joost J Smit; Hossein Hosseini; Sjef J De Kimpe; Frans P Nijkamp; Gert Folkerts
Journal:  Respir Res       Date:  2006-04-19
View more
  5 in total

1.  Effect of Pulmonary Rehabilitation in Patients with Asthma COPD Overlap Syndrome: A Randomized Control Trial.

Authors:  Munazza Orooj; Jamal Ali Moiz; Aqsa Mujaddadi; Mir Shad Ali; Deepak Talwar
Journal:  Oman Med J       Date:  2020-06-30

Review 2.  Roles of Myeloid and Lymphoid Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease.

Authors:  Ling Ni; Chen Dong
Journal:  Front Immunol       Date:  2018-06-21       Impact factor: 7.561

Review 3.  The Role of Toll-Like Receptors 2 and 4 in the Pathogenesis of Chronic Obstructive Pulmonary Disease.

Authors:  Karolina Sidletskaya; Tatyana Vitkina; Yulia Denisenko
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-06-23

4.  Role of Toll-Like Receptor 2 in Regulation of T-Helper Immune Response in Chronic Obstructive Pulmonary Disease.

Authors:  Karolina A Sidletskaya; Tatyana I Vitkina; Yulia K Denisenko; Elena E Mineeva
Journal:  Can Respir J       Date:  2021-08-13       Impact factor: 2.409

Review 5.  The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable Haemophilus influenzae.

Authors:  Yu-Ching Su; Farshid Jalalvand; John Thegerström; Kristian Riesbeck
Journal:  Front Immunol       Date:  2018-11-05       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.